Home CHARM Therapeutics

CHARM Therapeutics

In operation
Series B
Small Molecule Drug Developer
Basic
Enterprise Profile

Basic Information

CHARM Therapeutics Utilizes Deep Learning to Research 3D Molecular Configurations and Develop Molecular Therapies Targeting Pathogenic Proteins. Its Mission is to Leverage Insights in 3D Deep Learning to Address Challenging Targets in Cancer and Other Disease Areas, and to Discover and Develop New Drugs for Them. CHARM Therapeutics is Using its Proprietary 3D Deep Learning Platform, DragonFold, to Discover and Develop Small Molecule Drugs for Difficult-to-Drug Targets.
CHARM Therapeutics Inc.
London,England,United Kingdom
less than 15 people
January 01, 2021
laksh@charmtx.com

Enterprise Profile

Industrial Sector
New Drug Development
Technology
Deep Learning Targeted Technology Protein Technology
Concept
Tumor Therapeutic Products
Application Scenarios
Chemical Drug Innovative Drugs AI+Pharmaceuticals